RE: Buy18 May 2020 17:17
The second round of end user trials are underway on Paraytec's Innovate UK funded R&D project ("NEXUS"), which is developing instrumentation for measuring protein aggregation in biopharmaceuticals. Trials have already been conducted with Fujifilm Diosynth and members of Paraytec's scientific team will visit GlaxoSmithKline and Medimmune over the coming weeks. Protein aggregates are an impurity that must be controlled and must stay within product specifications, so measurement is essential to ensure that products containing protein aggregates meet the regulatory requirements.